Long term therapeutic effect for 3 years after treatment

According to data released at the end of 2015, the drug retains its effectiveness for at least 3 years after the treatment (Deev R.V., Kallinin R.E., Chervyakov Y.V. et al. Long-term results of treatment with pl-VEGF165 in patients with chronic lower limb ischemia caused by obliterating atherosclerosis).

Preliminary results of monitoring of patients after 4 and 5 years of treatment are also available, and according to this data therapeutic effect is still in place.